News & Updates
Filter by Specialty:
Statins linked to moderate increase in diabetes risk, but overall benefits bear more weight
Statin therapy appears to result in a modest elevation in blood sugar levels, increasing the likelihood of diabetes development especially among people whose blood sugar levels are already near the diagnostic threshold, according to a meta-analysis.
Statins linked to moderate increase in diabetes risk, but overall benefits bear more weight
09 Apr 2024Impaired glucose clearance determines hyperglycaemia in obese people
In individuals with obesity, fasting hyperglycaemia indicates an interruption of the “precisely regulated integration” of glucose production as well as clearance rates, reveals a study.
Impaired glucose clearance determines hyperglycaemia in obese people
26 Mar 2024Early vs late time-restricted eating: Which is more effective in NAFLD?
Early (eTRE) and late time-restricted eating (lTRE) both result in significantly reduced intrahepatic fat and improved body composition, liver function, and metabolic health among patients with nonalcoholic fatty liver disease (NAFLD), reports a study.
Early vs late time-restricted eating: Which is more effective in NAFLD?
26 Mar 2024Weight management improves biomarkers in men with prostate cancer
A weight management intervention results in better body composition, quality of life, and prostate cancer (PCa) biomarkers in men scheduled for prostatectomy, reports a study.
Weight management improves biomarkers in men with prostate cancer
25 Mar 2024Vitamin D falls short of improving sexual function in PCOS
Vitamin D supplementation does not appear to affect sexual dysfunction, while hormonal contraception (HC) appears to improve sexual function in women with polycystic ovary syndrome (PCOS), suggests a recent study.
Vitamin D falls short of improving sexual function in PCOS
25 Mar 2024Low-dose semaglutide spurs MASLD regression in people with HIV
Treatment with low-dose semaglutide helps reduce the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with HIV, according to data from the single-arm phase IIb ACTG A5371 trial.